Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease.

MLA

Evenberg, D., et al. “Preparation, Antigenicity, and Immunogenicity of Synthetic Ribosylribitol Phosphate Oligomer-Protein Conjugates and Their Potential Use for Vaccination against Haemophilus Influenzae Type b Disease.” The Journal of Infectious Diseases, vol. 165 Suppl 1, June 1992, pp. S152–55. EBSCOhost, https://doi.org/10.1093/infdis/165-supplement_1-s152.

APA

Evenberg, D., Hoogerhout, P., van Boeckel, C. A., Rijkers, G. T., Beuvery, E. C., van Boom, J. H., & Poolman, J. T. (1992). Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease. The Journal of Infectious Diseases, 165 Suppl 1, S152–S155. https://doi.org/10.1093/infdis/165-supplement_1-s152

Chicago

Evenberg, D, P Hoogerhout, C A van Boeckel, G T Rijkers, E C Beuvery, J H van Boom, and J T Poolman. 1992. “Preparation, Antigenicity, and Immunogenicity of Synthetic Ribosylribitol Phosphate Oligomer-Protein Conjugates and Their Potential Use for Vaccination against Haemophilus Influenzae Type b Disease.” The Journal of Infectious Diseases 165 Suppl 1 (June): S152–55. doi:10.1093/infdis/165-supplement_1-s152.